Purpose: To record visual and refractive data in eyes with previous radial keratotomy (RK) and corneal instability undergoing corneal cross-linking (CXL).
stress-bearing stroma because of interlamellar slippage and subsequent interfibrillar slippage. 1 Long-term follow-up has shown that ectatic radial keratotomy (RK) patients experience corneal instability, characterized by visual fluctuations, increase in spherical equivalent (SE), and hyperopic shifts. 2, 3 Hyperopic laser-assisted in situ keratomileusis (LASIK) has been shown to be effective in RK patients; however, cylindrical errors are difficult to correct, and astigmatic correction regresses over time. 4 Hence, visual rehabilitation in RK patients is still considered a challenge, regardless of whether laser-assisted techniques, phakic intraocular lenses (IOLs), or pseudophakic IOLs (monofocal, multifocal, multifocal toric, or piggy-back) are used. The fact that corneal cross-linking (CXL) has been proven to safely stiffen the anterior stroma (300 mm) in keratoconic corneas has led to its application in other diseases, like ectasia, pellucid marginal degeneration, bacterial ulcers, bullous keratopathy, ectasia prevention, and recently in one RK patient with keratoconus. [5] [6] [7] [8] [9] [10] [11] Animal-tested CXL properties like increased hydration resistance and formation of aggregated molecules lead us to believe that RK patients with corneal instability could also benefit from this procedure. 12, 13 We report short-term visual results after treating ectatic RK patients with CXL.
CASE REPORTS
We report a case series of eyes with RK and refractive instability (hyperopic shift) undergoing CXL with riboflavin and UV-A radiation (as initially described by Wollensak). 7 De-epithelization was cautiously performed to avoid incision breaks. CXL was followed by placement of therapeutic contact lenses, until epithelization was completed, and topical antibiotic for 7 days, and prednisolone was tapered during the following 3 weeks. The following variables were recorded before CXL and 3 and 6 months after CXL: sphere, topographic astigmatism, SE, uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), topographic pachymetry, mean topographic K (Km), and Q values. Visual acuity (VA) data were recorded as decimals, and all topographic measurements were performed with Scheimpflug topograph (Pentacam; Oculus, Inc). Statistical analysis was performed with SPSS (SPSS Inc., Chicago, IL) 11.5v; data were recorded as mean and standard deviation. Pearson correlation and Student t (paired samples) tests were used for data analysis. Table 1 shows visual results before CXL and 6 months after CXL, for corresponding eyes 3 and 4. Six months after CXL, topographic results of the RE were astigmatism, 0.7 D; pachymetry, 470 mm; and Q, 0.6; and those of the LE were astigmatism, 4.5 D and Q, 1.7. Nine months after CXL, an LE, toric, hyperopic, phakic IOL (ICL; Staar Surgical AG, Nidau, Switzerland) was successfully implanted. Table 2 shows clinical findings after 9 months and the LE IOL implantation for eyes 3 and 4 (corresponding eyes from Table 1 ).
Patient 3
Patient 3 is a 54-year-old woman, with a 20-year history of RK for 222 D, who manifested progressive VA decrease. Pre-CXL topographic values were as follows: RE astigmatism, 3.7 D and Q, 0.57; LE astigmatism, 1.2 D; Km, 44.9 D; pachymetry, 499 mm; and Q, 0.63. Table 1 shows visual results before CXL and 6 months after CXL, for corresponding eyes 5 and 6. Three months post-CXL, the RE data were UCVA, 0.3; BSCVA, 0.5 (22.75 2 2.25 3 0); Km, 48.6 D; topographic astigmatism, 1.2 D; pachymetry, 474 mm; and Q, 1.17 and the LE data were UCVA, 0.2; BSCVA, 0.4 (22.25 D); Km, 43.6 D; pachymetry, 478 mm; and Q, 0.50. Table 1 shows visual results 6 months after CXL: topographic RE astigmatism, 1.3 D; RE pachymetry, 454 mm; RE Q, 1.13; and LE Q, 1.15. Nine months after CXL, she underwent uneventful cataract surgery with RE implantation of a toric IOL (Acrysof Toric IOL SN60T9, 15.5 D Cyl 6.0 D at 99°; ALCON) and a monofocal IOL in her LE. Table 2 shows results after 1 year of follow-up and IOL implantation for corresponding eyes 5 and 6, from Table 1 . After 1 year, topographic astigmatism was 2.5 D in the RE and 1.0 in the LE, pachymetry was 474 mm in her RE and 478 mm in her LE, and no changes were recorded for Q. Figure 1 shows comparative topography before CXL and 1 year after RE CXL.
Patient 4
Patient 4 is a 60-year-old woman with pseudophakia, with a history of LE RK for 4 D myopia, who consulted because of the LE VA instability with her glasses. Table 1 shows visual results before CXL and 6 months after CXL, for corresponding eye 7. Three months later, we registered the following: LE UCVA, 0.3; BSCVA, 0.8 (23.00 3 60); topographic astigmatism, 1.1 D; Km, 35.4 D; pachymetry, 477 mm; and Q, 2.52. Six months after CXL, topographic values were as follows: astigmatism, 1.9 D; pachymetry, 476 mm; and Q, 2.81. Supplementary IOL sulcus implantation could eventually improve the anisometropy, once long-term corneal stability is verified. Table 3 compares global mean results throughout time, statistical significance, and correlation of findings. Figures 2 and 3 show mean VA follow-up and hyperopic shift of each treated eye, respectively. Figure 2 compares visual results before and 6 months after CXL, whereas Figure 3 shows case-by-case hyperopic shift, 3 and 6 months after CXL.
DISCUSSION
Visual acuity instability after RK occurs because of the long-term progressive hyperopic shift (at least 1 D) and myopic shifts because of intraocular pressure fluctuations. 2, 3 LASIK treatment for consecutive hyperopia was proven safe and effective in RK; however, cylindrical errors were not easily corrected and astigmatism regressed. 4 In RK, the residual stress-bearing stroma is almost 5% to 10% of posterior most stroma below the RK incisions, which fail through interlamellar slippage and subsequent interfibrillar slippage. 1 Corneal ectasia after RK can compromise final results, no matter which of all the available IOL options is chosen to rehabilitate these patients: phakic, accommodating, monofocal/toric, multifocal, or piggy-back. CXL is being widely applied to anteriorly stabilize corneas with keratoconus, marginal pellucid degeneration, bacterial ulcers, bullous keratopathy, orthokeratology, and post-LASIK ectasia. [7] [8] [9] Wollensak et al 12, 13 reported increased resistance to corneal swelling in porcine corneas treated with CXL, confirmed its main effect on the anterior cornea, and increased collagen fiber diameter. Ectatic RK patients could therefore benefit from these particular CXL effects by limiting intraocular pressure-associated myopic shifts. In addition, after CXL corneal refractive cylinder, topographic astigmatism, aberrations, and endothelial density remain stable in keratoconus. 8 Recently, Mazzotta et al 10 exacerbated by RK with hyperopic shift. They concluded that CXL was a promising option for handling corneal ectasia in RK patients with keratoconus and hypothesized that it diffusely stiffened the anterior stroma-midstroma, increased interlamellar connections, worked mostly on the hypercellular fibrotic stromal RK wound, and also increased the resistance of extracellular matrix proteoglycans. 11 In our RK patients, shortterm follow-up showed that all eyes improved postsurgical UCVA, and in 4 eyes, BSCVA improved at least by 3 Snellen lines, after CXL. In addition, VA improvement and the mean 1.2 D hyperopic shift, in our RK patients after CXL, could be attributed to collagen compaction and stiffening of the anterior 300-mm stroma. 6, 7, 10, 11, 14 Postoperative UCVA and BSCVA improvement were statistically significant, after 6 months of follow-up. In 2 eyes with a 1-year follow-up, both UCVA and BSCVA remained stable. No eyes lost Snellen lines, and no complications were recorded. Another interesting finding was that all our patients improved UCVA by at least 1 line and that the corneas with the most numerous incisions (12 radial and 6 arcuate) had the highest line gain, after 9 months. Also, 1 eye stabilized from 21.25 D and 0.4 UCVA to neutral with 1.0 UCVA, with 9-month follow-up. Three CXL-treated RK eyes had excellent UCVA after phakic (IOL) or pseudophakic IOL implantation, and VA improvement was also observed in another treated pseudophakic eye. Mean post-CXL sphere, SE, and pachymetry decrease were all statistically significant after 3 and 6 months. We also found that post-CXL changes for topographic astigmatism, as previously reported by Doors et al, 9 Km, and Q were not statistically significant. Also, our pre-and post-CXL data correlated significantly for most variables, except for the third-month UCVA and sixth-month topographic astigmatism. Whether VA improvement and corneal stability will last, to achieve long-term stability, after secondary phakic or pseudophakic IOL implantation for emmetropia remains to be evaluated. RK patients show short-term clinical and statistical visual improvement after CXL and can be further rehabilitated with IOL implantation. Basic investigations and a large cohort of patients with long-term follow-up are necessary to determine the real potentiality and efficacy of CXL in post-RK ectasia.
